Global Veterinary/Animal Vaccines Market Size By Type (Live Attenuated Vaccines, Inactivated Vaccines), By Application (Hospitals and Clinics, Others), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary/Animal Vaccines Market was valued at USD 13.2 billion in 2023 and is expected to reach USD 22.5 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. The market growth is propelled by increasing awareness of zoonotic diseases, rising livestock populations, and the expanding companion animal sector. In addition, stringent regulations mandating pet and livestock vaccinations, coupled with technological advancements in vaccine development such as DNA vaccines and recombinant vaccines, are driving further innovation and market penetration globally.

Drivers:

1. Rising Incidence of Zoonotic Diseases:

Growing outbreaks of diseases that can spread from animals to humans, such as rabies, avian influenza, and leptospirosis, are prompting governments and veterinarians to enforce strict vaccination programs, thereby fueling market demand.

2. Growth in Livestock Farming:

The increasing demand for animal-derived food products such as meat, milk, and eggs is resulting in the intensification of livestock farming practices. Vaccines are vital to disease prevention in densely populated farms, supporting productivity and ensuring food safety.

3. Advancements in Vaccine Technology:

Innovations such as live recombinant vaccines, conjugate vaccines, and needle-free delivery systems are revolutionizing the veterinary healthcare landscape, enabling faster, safer, and more effective immunization.

Restraints:

1. High Cost of Vaccines and Cold Chain Requirements:

The production, storage, and distribution of vaccines require temperature-controlled environments, making logistics costly—especially in developing regions. This can limit market access and impact adoption rates.

2. Regulatory and Approval Delays:

Veterinary vaccines are subject to rigorous regulatory approval processes, which can be time-consuming and delay product launches. Variability in regional guidelines also adds complexity for multinational manufacturers.

Opportunity:

1. Growing Pet Adoption and Spending on Companion Animal Health:

With the rising number of pet owners globally and increased humanization of pets, there is a surge in demand for preventive healthcare measures, including vaccines. This trend presents significant opportunities in the companion animal segment.

2. Emerging Markets in Asia-Pacific and Latin America:

Emerging economies are witnessing rising incomes, increasing awareness of animal health, and improved veterinary infrastructure. These regions offer untapped potential for vaccine manufacturers to expand their footprint.

Market by System Type Insights:

By vaccine type, the Live Attenuated Vaccines segment accounted for the largest share in 2023. These vaccines offer long-lasting immunity and are widely used for both livestock and pets. Meanwhile, the Recombinant Vaccines segment is expected to exhibit the fastest growth due to its precision, safety, and reduced side effects, making them ideal for modern preventive care.

Market by End-use Insights:

In terms of end-use, the Livestock segment dominated the market in 2023, contributing over 65% of the revenue share. This is attributed to mass vaccination programs for cattle, poultry, and swine across regions to prevent outbreaks that could severely impact food supply chains. The Companion Animals segment is also poised for rapid growth, driven by rising pet adoption, increasing disposable incomes, and heightened focus on preventive healthcare.

Market by Regional Insights:

North America led the global veterinary vaccines market in 2023, underpinned by robust veterinary healthcare infrastructure, high pet ownership rates, and aggressive immunization policies. However, the Asia-Pacific region is anticipated to be the fastest-growing market during the forecast period. Factors such as increasing livestock farming, government vaccination drives, and rising awareness among farmers are expected to propel regional growth.

Competitive Scenario:

Key players in the global veterinary/animal vaccines market include:

Zoetis Inc.

Merck Animal Health

Boehringer Ingelheim Vetmedica, Inc.

Elanco Animal Health

Virbac

Ceva Santé Animale

Phibro Animal Health Corporation

HIPRA

Vetoquinol

Biogénesis Bagó

These companies are focusing on portfolio expansion, geographical diversification, and strategic acquisitions. For example:

In 2023, Zoetis launched a new mRNA-based vaccine for swine flu prevention, marking a technological leap in veterinary immunology.

In 2024, Elanco completed the acquisition of a South American vaccine manufacturing firm to strengthen its emerging market footprint.

Boehringer Ingelheim, in 2022, announced a collaboration with biotech firms to co-develop intranasal vaccines for canine respiratory diseases.

Scope of Work – Global Veterinary/Animal Vaccines Market

Report Metric Details

Market Size (2023) USD 13.2 billion

Projected Market Size (2031) USD 22.5 billion

CAGR (2023–2031) 6.9%

Key Segments By Vaccine Type, End-use, Region

Leading Segment by Vaccine Type Live Attenuated Vaccines

Leading Segment by End-use Livestock

Leading Region North America

Key Players Zoetis, Merck, Elanco, Boehringer Ingelheim, etc.

Growth Drivers Zoonotic diseases, livestock demand, innovation

Opportunities Pet care spending, emerging markets

Key Market Developments:

2023: Zoetis unveiled its latest range of combination vaccines for bovine respiratory diseases.

2024: Virbac introduced a new injectable vaccine targeting emerging swine pathogens in Southeast Asia.

2025: HIPRA launched a global pilot project deploying AI-powered platforms to predict vaccine schedules based on animal health analytics.

FAQs:

1. What is the current market size of the Global Veterinary/Animal Vaccines Market?

The market was valued at USD 13.2 billion in 2023.

2. What is the major growth driver of the Global Veterinary/Animal Vaccines Market?

The primary growth drivers include rising zoonotic disease prevalence and the increasing global livestock population.

3. Which is the largest region during the forecast period in the Global Veterinary/Animal Vaccines Market?

North America holds the largest market share due to advanced veterinary infrastructure and strong adoption of preventive care.

4. Which segment accounted for the largest market share in the Global Veterinary/Animal Vaccines Market?

The Livestock segment led the market in 2023, driven by widespread vaccination efforts in cattle, poultry, and swine.

5. Who are the key market players in the Global Veterinary/Animal Vaccines Market?

Key players include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, and Virbac.

Let me know if you'd like this in a downloadable format or tailored for a specific region or subsegment!